Duchenne Muscular Dystrophy Clinical Trial
Official title:
The Evaluation of Muscle Activation in Climbing up Stairs Activity in Children With Duchenne Muscular Dystrophy
NCT number | NCT04287582 |
Other study ID # | GO 19/323 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | April 3, 2019 |
Est. completion date | April 1, 2020 |
Children with Duchenne Muscular Dystrophy (DMD) have difficulties towards the end of the
ambulatory period, especially in activities that require lower extremity proximal muscle
strength such as walking, climbing stairs, standing up without sitting. Stair climbing /
descending activity is a complex activity that requires joint stability, correct muscle
synergy and timing. When the literature is examined; It has been observed that the
performance of stair climb up and down activity in individuals with neuromuscular disease has
been evaluated with various clinical applications. In recent studies, there are surface
electromyography (EMG) studies evaluating various aspects of stair climbing and descending
activity.
Surface EMG; is a technique for neuromuscular evaluations that is frequently used in both
research and clinical applications, noninvasive, and can be used in areas such as
neurophysiology, sports science and rehabilitation.
Our study was planned to examine the muscle activations in the lower limb muscles involved in
climbing up stairs activity in children with DMD and to compare healthy children with
children with DMD and children with different levels of DMD.
Hypothesis originating from the investigation:
H0: There is no difference in the muscle activations measured by surface electromyography
(EMG) of the involved lower extremity muscles during climbing up stairs activity between
level 1 and level 2-3 children with early DMD.
H1: There is a difference in the muscle activations measured by surface electromyography
(EMG) of the involved lower extremity muscles during climbing up stairs activity between
level 1 and level 2-3 children with early DMD.
H2: There is no difference in the muscle activations measured by surface electromyography
(EMG) of the involved lower extremity muscles during climbing up stairs activity between
children with DMD and healthy children.
H3: There is a difference in the muscle activations measured by surface electromyography
(EMG) of the involved lower extremity muscles during climbing up stairs activity between
children with DMD and healthy children.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | April 1, 2020 |
Est. primary completion date | March 7, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 5 Years to 12 Years |
Eligibility |
Inclusion Criteria: Children with DMD: - Having been diagnosed with Duchenne Muscular Dystrophy by a pediatric neurologist, - Volunteering to participate in the study, - Being in the 5-12 age range - According to the Brooke Lower Limb Functional Classification developed for classifying lower extremity functions of children with DMD, it should be between level 1-3 (children who continue ambulation and can go up and down with assisted / unassisted stairs), - To be able to cooperate with the instructions of the physiotherapist Healthy Group: - Not having a known acute or chronic illness - The children with DMD included in the study have similar demographic characteristics (age, height, weight, body mass index), - The physiotherapist should cooperate with the instructions. Exclusion Criteria: Children with DMD: - Have undergone any lower limb injuries and / or surgery, - Started steroid treatment in the last 6 months, - Having any systemic disease other than DMD, - Not having permission from his family and himself. Healthy Group: - Having had any injury and / or surgery , - Children with DMD have relatives, - Not having permission from his family and himself |
Country | Name | City | State |
---|---|---|---|
Turkey | Hacettepe University | Ankara |
Lead Sponsor | Collaborator |
---|---|
Hacettepe University |
Turkey,
Bakker JP, De Groot IJ, Beelen A, Lankhorst GJ. Predictive factors of cessation of ambulation in patients with Duchenne muscular dystrophy. Am J Phys Med Rehabil. 2002 Dec;81(12):906-12. — View Citation
Hermens HJ, Freriks B, Disselhorst-Klug C, Rau G. Development of recommendations for SEMG sensors and sensor placement procedures. J Electromyogr Kinesiol. 2000 Oct;10(5):361-74. — View Citation
Rainoldi A, Melchiorri G, Caruso I. A method for positioning electrodes during surface EMG recordings in lower limb muscles. J Neurosci Methods. 2004 Mar 15;134(1):37-43. — View Citation
Ropars J, Lempereur M, Vuillerot C, Tiffreau V, Peudenier S, Cuisset JM, Pereon Y, Leboeuf F, Delporte L, Delpierre Y, Gross R, Brochard S. Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy. PLoS One. 2016 Sep 13;11(9):e0161938. doi: 10.1371/journal.pone.0161938. eCollection 2016. — View Citation
Uchikawa K, Liu M, Hanayama K, Tsuji T, Fujiwara T, Chino N. Functional status and muscle strength in people with Duchenne muscular dystrophy living in the community. J Rehabil Med. 2004 May;36(3):124-9. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Surface Electromyographic Measurement | Muscle Activation Measurement It is an 8-channel system for measuring signals come from muscles (Delsys) | 40 minutes | |
Secondary | Muscle Strength Measurement | A quantitative and objective method for assessment of muscular strength using a portable hand held dynamometer. Muscle strength measurement included lower limb and trunk muscles. | 15 minutes | |
Secondary | Timed Performance Test | Timed function tests included time taken to stand from a supine position, time taken to walk 10 m, time taken to climb 4 standard-sized stairs and time taken to descend 4 standard-sized stairs. | 20 minutes | |
Secondary | Muscle shortness assessment | Shortening assessment of trunk and lower extremity muscles measurement included back extensors, hamstring, hip flexors, quadriceps and gastrocnemius muscles. | 10 minutes | |
Secondary | Six minute walk test | Children were asked to walk during 6 minutes as fast as possible at a 25 meter corridor. | 6 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05575648 -
Dual Task in Duchenne Muscular Dystrophy
|
N/A | |
Terminated |
NCT03907072 -
Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06450639 -
An Open-label Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy
|
Phase 2 | |
Completed |
NCT04335942 -
Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor
|
N/A | |
Active, not recruiting |
NCT04906460 -
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02500381 -
Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)
|
Phase 3 | |
Enrolling by invitation |
NCT05967351 -
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
|
Phase 3 | |
Recruiting |
NCT03067831 -
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
|
Phase 1/Phase 2 | |
Recruiting |
NCT01834040 -
Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy
|
Phase 1/Phase 2 | |
Completed |
NCT02246478 -
A Study of TAS-205 for Duchenne Muscular Dystrophy
|
Phase 1 | |
Active, not recruiting |
NCT01772043 -
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
|
N/A | |
Terminated |
NCT01168908 -
Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
|
Phase 2 | |
Completed |
NCT00758225 -
Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
|
Phase 2 | |
Completed |
NCT03680365 -
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
|
||
Recruiting |
NCT03513367 -
The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM.
|
||
Recruiting |
NCT05712447 -
Duchenne Muscular Dystrophy Video Assessment Registry
|
||
Recruiting |
NCT01484678 -
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
|
||
Completed |
NCT03319030 -
Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)
|
||
Terminated |
NCT01753804 -
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
|
N/A | |
Completed |
NCT02530905 -
Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients
|
Phase 1 |